Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging

R Nuri Sener1

  • 1Department of Radiology, Ege University Hospital, Bornova, Izmir, Turkey.

Insights

Pantothenate kinase-associated neurodegeneration (PKAN) is a rare neurological disorder. This case highlights dynamic MRI findings in a young male, showing the "eye-of-the-tiger" sign evolution and characteristic spectroscopic changes.

Area of Science:

  • Neuroscience
  • Radiology
  • Genetics

Background:

  • Pantothenate kinase-associated neurodegeneration (PKAN) is a rare, inherited neurodegenerative disorder.
  • It is characterized by progressive dystonia, spasticity, and cognitive decline.
  • Genetic mutations in the PANK2 gene are the primary cause of PKAN.

Observation:

  • A 15-year-old male presented with symptoms consistent with PKAN.
  • Initial T2-weighted MRI revealed the classic "eye-of-the-tiger" sign in the globus pallidi, which resolved by 10-month follow-up.
  • FLAIR MRI demonstrated hypointensity in globus pallidi and dentate nuclei, with white matter hyperintensities.

Findings:

  • Proton MR spectroscopy showed reduced N-acetylaspartate (NAA) in the globus pallidi and deep white matter, with increased myoinositol in the white matter.
  • Diffusion-weighted imaging (DWI) at b=1000 s/mm(2) showed normal-appearing deep white matter, but with slightly increased apparent diffusion coefficient (ADC) values.
  • ADC values in the globus pallidi were lower than in the thalamus, suggesting altered tissue microstructure.

Implications:

  • The dynamic changes in the "eye-of-the-tiger" sign underscore the importance of serial MRI in PKAN diagnosis and monitoring.
  • Advanced MRI techniques, including spectroscopy and diffusion imaging, provide crucial insights into the pathophysiology of PKAN.
  • Understanding these imaging biomarkers can aid in early diagnosis, disease progression assessment, and potentially therapeutic interventions for PKAN.

Related Concept Videos